| Pharmaceutical active ingredients: |
| Dipyridamole |
| Available forms, composition and doses of Persantin Retard: |
| Capsules, Modified Release; Oral; Dipyridamole 200 mg |
| Persantin Retard medical category: |
| Human:Anti-anginal drugsAnticoagulants, antiplatelets and fibrinolytics (thrombolytics)Miscellaneous vasodilatating agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B01AC07 - Dipyridamole |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Boehringer Ingelheim |